PF-05221304

CAS No. 1370448-25-1

PF-05221304( NSC 170984, R 6238, STAT5 Inhibitor III )

Catalog No. M23101 CAS No. 1370448-25-1

PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 255 In Stock
5MG 167 In Stock
10MG 252 In Stock
25MG 437 In Stock
50MG 556 In Stock
100MG 809 In Stock
200MG 1088 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PF-05221304
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).
  • Description
    PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 170984, R 6238, STAT5 Inhibitor III
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1370448-25-1
  • Formula Weight
    502.57
  • Molecular Formula
    C28H30N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)N1C2=C(CC3(CCN(C(C4=CC(C5=CC=C(C(O)=O)C=C5)=NC(OC)=C4)=O)CC3)CC2=O)C=N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (3beta,7beta,12beta,...

    (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid, a lanostane triterpenoid, demonstrates significant inhibitory effects on nitric oxide (NO) production in BV-2 microglia cells induced by n LPS, with an IC50 value of 9.55 uM.

  • Bractoppin

    Bractoppin is a drug-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem (t)BRCT domain (IC50 = 0.074 μM), which selectively inhibits substrate binding with nanomolar potency in vitro.

  • Splendoside

    Splendoside is a natural product of Vaccinium, Ericaceae. Splendoside can be used as a reference standard.